Boehringer Ingelheim Gmbh

Sigfrid Puschmann

Johannes Keck

Gerd Kruger

Helmut Pieper

Klaus-Reinhold Noll

Matyas Leitold

Gunther Engelhardt

Gunther Schmidt

Compounds of the formula ##STR1## wherein R.sub.1 --is hydrogen, alkyl of 1 to 6 carbon atoms or benzyl;

2-Methyl-6-alkyl-11-aminoalkyl-6,11-dihydro-5H-pyrido(2,3-B)(1,5)benzodia

Compounds of the formula ##STR1## wherein X and R.sub.1 are each chlorine or bromine;

2- OR 4-Hydroxy-3,5-dihalo-benzylamines and salts thereof

Compounds of the formula ##STR1## wherein R.sub.1 is hydrogen or aliphatic or aromatic carboxylic acyl,

Aminobenzyl-amines and salts thereof

Compounds of the formula ##STR1## wherein X is chlorine or bromine;

Halo-substituted hydroxybenzyl-amines as secretolytic agents

Compounds of the formula ##STR1## wherein R.sub.1 is hydrogen, straight or branched alkyl of 1 to 3 carbon atoms or benzyl,

11-Aminoalkyl-pyridobenzodiazepinones and salts thereof

Pharmaceutical dosage unit compositions containing as an active ingredient a compound of the formula ##STR1## wherein R.sub.1 is hydrogen, lower alkanoyl, benzoyl or halobenzoyl,

Pharmaceutical compositions containing an aminobenzyl-amine and method

Pharmaceutical compositions containing as an active ingredient an N-(hydroxy-cyclohexyl)-benzylamine of the formula ##SPC1## Wherein R.sub.1 is hydrogen or methyl, or a non-toxic, pharmacologically acceptable acid addition salt thereof; and a method of using the same as anti-ulcerogenics.

Anti-ulcerogenic pharmaceutical compositions containing a

Compounds of the formula ##SPC1## Wherein

Growing community of inventors

Biberach an der Riss, Germany

Sigfrid Puschmann